Incyte (INCY)
(Delayed Data from NSDQ)
$68.06 USD
+1.96 (2.97%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $67.78 -0.28 (-0.41%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for Incyte Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 597.60 | 340.66 | 948.58 | -295.70 | 446.91 |
Depreciation/Amortization & Depletion | 82.66 | 67.86 | 57.84 | 51.81 | 54.53 |
Net Change from Assets/Liabilities | -248.65 | 198.81 | -14.57 | -71.74 | 57.30 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 64.88 | 362.62 | -242.37 | 191.03 | 151.92 |
Net Cash From Operating Activities | 496.49 | 969.94 | 749.49 | -124.60 | 710.66 |
Property & Equipment | -32.49 | -77.83 | -181.01 | -187.38 | -78.06 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -160.19 | -0.71 | -26.69 | -81.62 | -9.39 |
Other Investing Activities | -15.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -207.68 | -78.54 | -207.70 | -269.00 | -87.45 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 35.84 | 61.12 | 58.63 | 110.31 | 63.30 |
Issuance (Repayment) of Debt | -3.36 | -2.86 | -2.42 | -0.84 | -0.82 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -52.51 | -59.05 | -50.03 | -37.76 | -16.77 |
Net Cash from Financing Activities | -20.03 | -0.79 | 6.18 | 71.71 | 45.71 |
Effect of Exchange Rate Changes | -6.68 | 3.36 | -3.57 | 2.95 | -0.19 |
Net Change In Cash & Equivalents | 262.10 | 893.96 | 544.40 | -318.94 | 668.72 |
Cash at Beginning of Period | 2,953.12 | 2,059.16 | 1,514.77 | 1,833.71 | 1,164.99 |
Cash at End of Period | 3,215.22 | 2,953.12 | 2,059.16 | 1,514.77 | 1,833.71 |
Diluted Net EPS | 2.65 | 1.52 | 4.27 | -1.36 | 2.05 |
Fiscal Year End for Incyte Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -275.05 | 169.55 | 597.60 | 396.52 | 225.25 |
Depreciation/Amortization & Depletion | 44.00 | 21.95 | 82.66 | 60.90 | 39.51 |
Net Change from Assets/Liabilities | -54.22 | 99.24 | -248.65 | -175.40 | -84.28 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Other Operating Activities | -71.48 | -71.92 | 64.88 | 66.74 | 20.44 |
Net Cash From Operating Activities | -356.75 | 218.81 | 496.49 | 348.76 | 200.92 |
Property & Equipment | -63.69 | -9.55 | -32.49 | -30.22 | -19.24 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Investments | 205.80 | -63.56 | -160.19 | -7.96 | -1.74 |
Other Investing Activities | -1.40 | 0.00 | -15.00 | -15.00 | -15.00 |
Net Cash from Investing Activities | 140.71 | -73.11 | -207.68 | -53.18 | -35.99 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -1,989.73 | 0.48 | 35.84 | 28.32 | 28.37 |
Issuance (Repayment) of Debt | -1.78 | -0.87 | -3.36 | -2.52 | -1.64 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Other Financing Activities | -18.08 | -12.02 | -52.51 | -46.18 | -9.85 |
Net Cash from Financing Activities | -2,009.59 | -12.41 | -20.03 | -20.38 | 16.88 |
Effect of Exchange Rate Changes | -0.66 | -0.68 | -6.68 | 0.63 | -2.09 |
Net Change In Cash & Equivalents | -2,226.30 | 132.61 | 262.10 | 275.83 | 179.72 |
Cash at Beginning of Period | 3,215.22 | 3,215.22 | 2,953.12 | 2,953.12 | 2,953.12 |
Cash at End of Period | 988.92 | 3,347.83 | 3,215.22 | 3,228.95 | 3,132.84 |
Diluted Net EPS | -2.04 | 0.75 | 0.89 | 0.76 | 0.90 |